AI
-
Business & Markets · Startups RevolKa Announces the Closing of a $1.7M Series A Extension Funding to Accelerate Drug-Discovery Programs
Insider Brief RevolKa has secured 250 million JPY (US$1.7M) in Series A extension funding to advance its AI-driven protein engineering platform, aiProtein®, and launched a drug discovery program for rare diseases. The funds, co-led… -
Business & Markets · Startups AI Coding Startup Magic Secures $320M Investment from Eric Schmidt, Atlassian & Leading Investors
-
Technology & Infrastructure · Data centres & compute Yale Announces $150M to Support Leadership in AI
-
Policy & Government · AI Safety OpenAI & Anthropic Partner with US AI Safety Institute for Pre-Release Testing of New Models
-
Business & Markets · Startups GSTS Closes Series A Funding Round for Global Commercialization of OCIANA® Platform
-
Business & Markets · Startups Noetik Secures $40M Series A Financing to Advance Precision Cancer Therapies
-
Technology & Infrastructure · Models & LLMs AI is Tool for Enhancing Human Communication, Believes Stanford’s Russ Altman
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.